{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:17:26Z","timestamp":1771082246293,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Artif. Intell."],"abstract":"<jats:p>COVID-19 is an unprecedented global pandemic with a serious negative impact on virtually every part of the world. Although much progress has been made in preventing and treating the disease, much remains to be learned about how best to treat the disease while considering patient and disease characteristics. This paper reports a case study of combinatorial treatment selection for COVID-19 based on real-world data from a large hospital in Southern China. In this observational study, 417 confirmed COVID-19 patients were treated with various combinations of drugs and followed for four weeks after discharge (or until death). Treatment failure is defined as death during hospitalization or recurrence of COVID-19 within four weeks of discharge. Using a virtual multiple matching method to adjust for confounding, we estimate and compare the failure rates of different combinatorial treatments, both in the whole study population and in subpopulations defined by baseline characteristics. Our analysis reveals that treatment effects are substantial and heterogeneous, and that the optimal combinatorial treatment may depend on baseline age, systolic blood pressure, and c-reactive protein level. Using these three variables to stratify the study population leads to a stratified treatment strategy that involves several different combinations of drugs (for patients in different strata). Our findings are exploratory and require further validation.<\/jats:p>","DOI":"10.3389\/frai.2023.1123285","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:29:49Z","timestamp":1680499789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Learning from real world data about combinatorial treatment selection for COVID-19"],"prefix":"10.3389","volume":"6","author":[{"given":"Song","family":"Zhai","sequence":"first","affiliation":[]},{"given":"Zhiwei","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jiayu","family":"Liao","sequence":"additional","affiliation":[]},{"given":"Xinping","family":"Cui","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"B1","first-page":"176","article-title":"Classification with class imbalance problem: a review","volume":"7","author":"Ali","year":"2015","journal-title":"Int. J. Adv. Soft Comput. Applic."},{"key":"B2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fmed.2020.00458","article-title":"Relationship between COVID-19 infection and liver injury: a review of recent data","volume":"7","author":"Ali","year":"2020","journal-title":"Front. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/jpm11090886","article-title":"Application of artificial intelligence in COVID-19 diagnosis and therapeutics","volume":"11","author":"Asada","year":"2021","journal-title":"J. Pers. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17476348.2021.1927719","article-title":"Antiviral treatment selection for SARS-CoV-2 pneumonia","volume":"15","author":"Bassetti","year":"2021","journal-title":"Expert Rev. Respir. Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B6","article-title":"A gentle introduction to imbalanced classification","author":"Brownlee","year":"2019","journal-title":"Mach. Learn. Mastery"},{"key":"B7","article-title":"Loss functions for binary class probability estimation and classification: structure and applications","author":"Buja","year":"2005","journal-title":"Working Draft"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/sj.bjc.6601907","article-title":"Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines","volume":"91","author":"Burton","year":"2004","journal-title":"Br. J. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"J. Artif. Intellig. Res."},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1201\/9780429030888","volume-title":"Handbook of Multiple Comparisons.","author":"Cui","year":"2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"A gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10916-021-01757-0","article-title":"Application of big data and artificial intelligence in COVID-19 prevention, diagnosis, treatment and management decisions in china","volume":"45","author":"Dong","year":"2021","journal-title":"J. Med Syst."},{"key":"B13","volume-title":"The Design of Experiments","author":"Fisher","year":"1935"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1002\/sim.4322","article-title":"Subgroup identification from randomized clinical trial data","volume":"30","author":"Foster","year":"2011","journal-title":"Stat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/oxfordjournals.aje.a117592","article-title":"A critical look at methods for handling missing covariates in epidemiologic regression analyses","volume":"142","author":"Greenland","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1038\/s41598-021-93500-5","article-title":"Informing selection of drugs for COVID-19 treatment through adverse events analysis","volume":"11","author":"Guo","year":"2021","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"E1225","DOI":"10.3390\/jcm9041225","article-title":"The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control","volume":"9","author":"Helmy","year":"2020","journal-title":"J. Clin. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1214\/aos\/1176346732","article-title":"Constrained simultaneous confidence intervals for multiple comparisons with the best","volume":"12","author":"Hsu","year":"1984","journal-title":"Ann. Stat."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/biomet\/87.3.706","article-title":"The role of the propensity score in estimating dose-response functions","volume":"87","author":"Imbens","year":"2000","journal-title":"Biometrika"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1162\/003465304323023651","article-title":"Nonparametric estimation of average treatment effects under exogeneity: a review","volume":"86","author":"Imbens","year":"2004","journal-title":"Rev. Econ. Stat."},{"key":"B22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s41999-020-00356-5","article-title":"Clinical and CT features of the COVID-19 infection: comparison among four different age groups","volume":"11","author":"Li","year":"2020","journal-title":"Eur. Geriatr. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.48550\/arXiv.1701.05306","article-title":"Estimating individual treatment effect in observational data using random forest methods","volume":"27","author":"Lu","year":"2018","journal-title":"J. Comput. Graphical Stat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"m4130","DOI":"10.1136\/bmj.m4130","article-title":"Covid-19: why are age and obesity risk factors for serious disease?","volume":"371","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"B25","volume-title":"Theoretical Epidemiology: Principles of Occurrence Research in Medicine","author":"Miettinen","year":"1985"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1516","article-title":"Toxicity prediction based on artificial intelligence: A multidisciplinary overview","author":"Perez Santin","year":"2021","journal-title":"Wiley Interdisciplinary Reviews: Computational Molecular Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/0270-0255(86)90088-6","article-title":"A new approach to causal inference in mortality studies with a sustained exposure period\u2014application to control of the healthy worker survivor effect","volume":"7","author":"Robins","year":"1986","journal-title":"Math. Modell."},{"key":"B28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archinte.1939.00190030002001","article-title":"Range of normal blood pressure: a statistical and clinical study of 11,383 persons","volume":"64","author":"Robinson","year":"1939","journal-title":"Arch. Intern. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/01621459.1984.10477060","article-title":"From association to causation in observation studies: the role of tests of strongly ignorable treatment assignment","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J. Am. Stat. Assoc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"B32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassification on the propensity score","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J. Am. Stat. Assoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum","year":"1985","journal-title":"Am. Stat."},{"key":"B34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1037\/h0037350","article-title":"Estimating causal effects of treatments in randomized and nonrandomized studies","volume":"66","author":"Rubin","year":"1974","journal-title":"J. Educ. Psychol."},{"key":"B35","volume-title":"Semiparametric Theory and Missing Data.","author":"Tsiatis","year":"2006"},{"key":"B36","unstructured":"\u201cUnified cross-validation methodology for selection among estimators and a general cross-validated adaptive epsilon-net estimator: finite sample oracle inequalities and examples,\u201d\n            Van Der LaanM. J.\n            DudoitS.\n          UC Berkeley Division of Biostatistics Working Paper Series2003"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-21700-0","volume-title":"Unified Methods for Censored Longitudinal Data and Causality","author":"Van Der Laan","year":"2003"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-9782-1","volume-title":"Targeted Learning: Causal Inference for Observational and Experimental Data","author":"Van Der Laan","year":"2011"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jinf.2020.04.010","article-title":"Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China","volume":"81","author":"Wei","year":"2020","journal-title":"J. Infect."},{"key":"B40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s40495-020-00216-7","article-title":"An update on current therapeutic drugs treating COVID-19","volume":"6","author":"Wu","year":"2020","journal-title":"Curr. Pharmacol. Rep."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.imed.2021.09.001","article-title":"Artificial intelligence for COVID-19: battling the pandemic with computational intelligence","author":"Xu","year":"2022","journal-title":"Intell. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/j.jinf.2020.03.059","article-title":"Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis","volume":"81","author":"Zuin","year":"2020","journal-title":"J. Infect."}],"container-title":["Frontiers in Artificial Intelligence"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frai.2023.1123285\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:30:01Z","timestamp":1680499801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frai.2023.1123285\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":43,"alternative-id":["10.3389\/frai.2023.1123285"],"URL":"https:\/\/doi.org\/10.3389\/frai.2023.1123285","relation":{},"ISSN":["2624-8212"],"issn-type":[{"value":"2624-8212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"article-number":"1123285"}}